Cytoreductive Surgery and HIPEC for Peritoneal Carcinomatosis in the Elderly

被引:12
|
作者
Spiliotis, J. D. [1 ,2 ]
Halkia, E. [1 ,2 ]
Boumis, V. A. [1 ]
Vassiliadou, D. T. [1 ]
Pagoulatou, A. [3 ]
Efstathiou, E. [1 ,2 ]
机构
[1] Metaxa Canc Hosp, Dept Surg, Botassi 51, Piraeus 18537, Greece
[2] Hellen Soc Peritoneal Surface Malignancy, Piraeus 18537, Greece
[3] Metaxa Canc Hosp, Dept Anesthesiol, Piraeus, Greece
关键词
D O I
10.1155/2014/987475
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background. The combined treatment of peritoneal carcinomatosis with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy is a rigorous surgical treatment, most suitable for young and good performance status patients. We evaluated the outcomes of elderly patients undergoing CRS and HIPEC for peritoneal carcinomatosis with careful perioperative care. Methods. All consecutive patients 70 years of age or older who were treated for peritoneal carcinomatosis over the past five years were included. Primary outcomes were perioperative morbidity and mortality. Secondary outcomes were disease-free survival and overall survival. Results. From a pool of 100 patients, with a diagnosis of PC who underwent CRS and HIPEC in our center, we have included 30 patients at an age of 70 years or older and the results were compared to the patients younger than 70 years. The total morbidity rate was 50% versus 41.5% in the group younger than 70 years (NSS). The mortality rate was 3.3% in the elderly group versus 1.43% in the younger group (NSS). Median overall survival was 30 months in the older group versus 38 months in the younger group. Conclusion. Cytoreductive surgery and HIPEC for peritoneal carcinomatosis may be safely performed with acceptable morbidity in selected elderly patients.
引用
收藏
页数:5
相关论文
共 50 条
  • [21] Predictors of Severe Morbidity After Cytoreductive Surgery and HIPEC in Patients with Colorectal Peritoneal Carcinomatosis
    Simkens, G.
    van Oudheusden, T.
    Luyer, M.
    Nienhuijs, S.
    Nieuwenhuijzen, G.
    Rutten, H.
    de Hingh, I.
    ANNALS OF SURGICAL ONCOLOGY, 2016, 23 : S79 - S79
  • [22] Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for colorectal and appendiceal carcinomas with peritoneal carcinomatosis
    Pallas, Nicolaos
    Karamveri, Christina
    Kyziridis, Dimitrios
    Hristakis, Christos
    Kyriakopoulos, Vasileios
    Kalakonas, Apostolos
    Vaikos, Dimitrios
    Tentes, Antonios-Apostolos K.
    JOURNAL OF BUON, 2017, 22 (06): : 1547 - 1553
  • [23] Second Cytoreductive Surgery and HIPEC for Peritoneal Surface Malignancy and Peritoneal Carcinomatosis: Single Institution's Experience
    Wong, J.
    Teo, M.
    Tan, G.
    Tham, C.
    Soo, K.
    ANNALS OF SURGICAL ONCOLOGY, 2013, 20 : S109 - S109
  • [24] Is cholecystectomy and removal of the round ligament of the liver a necessary step in cytoreductive surgery and HIPEC, for peritoneal carcinomatosis?
    Halkia, Evgenia
    Kopanakis, Nikos
    Valavanis, Christos
    Nikolaou, George
    Zouridis, Andreas
    Vafias, Evangelos
    Datsis, Anastasios
    Spiliotis, John
    ANNALI ITALIANI DI CHIRURGIA, 2015, 86 (04) : 323 - 326
  • [25] HIPEC WITH CYTOREDUCTIVE SURGERY CAN CURE PATIENTS WITH LIMITED PERITONEAL CARCINOMATOSIS FROM ADENOCARCINOMA OF THE URACHUS
    Behrendt, Mark
    Mehta, Akash
    van de Putte, Elisabeth Fransen
    Van der Heijden, Michiel
    Horenblas, Simon
    Moonen, Luc
    Verwaal, Vic
    Meinhardt, Wim
    Van Rhijn, Bas
    JOURNAL OF UROLOGY, 2017, 197 (04): : E429 - E429
  • [26] Repeated cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with recurrent peritoneal carcinomatosis
    Vassos, Nikolaos
    Foertsch, Thomas
    Aladashvili, Archil
    Hohenberger, Werner
    Croner, Roland S.
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2016, 14
  • [27] Reoperation combining re-cytoreductive surgery and re-HIPEC for recurrent peritoneal carcinomatosis
    Spiliotis, J.
    Vaxevanidou, A.
    Halkia, E.
    Hadjigeorgiou, G.
    Datsis, A.
    JOURNAL OF BUON, 2012, 17 (03): : 522 - 525
  • [28] Cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with gastric cancer and peritoneal carcinomatosis
    Rihuete Caro, Cristina
    Manzanedo, Israel
    Pereira, Fernando
    Carrion-Alvarez, Lucia
    Serrano, Angel
    Perez-Viejo, Estibalitz
    EJSO, 2018, 44 (11): : 1805 - 1810
  • [29] Repeated cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with recurrent peritoneal carcinomatosis
    Nikolaos Vassos
    Thomas Förtsch
    Archil Aladashvili
    Werner Hohenberger
    Roland S. Croner
    World Journal of Surgical Oncology, 14
  • [30] Cytoreductive surgery associated with hyperthermic intraperitoneal chemotherapy (HIPEC) for treatment of peritoneal carcinomatosis of colorectal origin
    Cioppa, T.
    Vaira, M.
    Bing, C.
    D'Amico, S.
    Caponi, A.
    Fiorentin, G.
    De Simone, M.
    GIORNALE DI CHIRURGIA, 2009, 30 (05): : 196 - 200